Show simple item record

dc.contributor.authorLamarca, Angela
dc.contributor.authorFoster, L.
dc.contributor.authorValle, Juan W
dc.contributor.authorSatyadas, T.
dc.contributor.authorSiriwardena, A.
dc.date.accessioned2020-12-08T05:36:34Z
dc.date.available2020-12-08T05:36:34Z
dc.date.issued2020en
dc.identifier.citationLamarca A, Foster L, Valle JW, Satyadas T, Siriwardena A. FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out? ESMO Open. 2020;5(5).en
dc.identifier.pmid33122352en
dc.identifier.doi10.1136/esmoopen-2019-000633en
dc.identifier.urihttp://hdl.handle.net/10541/623508
dc.description.abstractNoneen
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1136/esmoopen-2019-000633en
dc.titleFOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDepartment of Medical Oncology, The Christie NHS Foundation Trust; Division of Cancer Sciences, University of Manchester, Manchester, UK.en
dc.identifier.journalESMO Openen
dc.description.noteen]
refterms.dateFOA2020-12-09T10:24:21Z


Files in this item

Thumbnail
Name:
33122352.pdf
Size:
914.9Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record